Dr Reddys Laboratories Ltd.
| Report Date | Research house | Description | Reco | At Price | Target Price | UpSide
/DownSide | Download |
|
2-Dec-22
|
NVS Wealth
|
Dr. Reddy’s Laboratories Ltd. (DRL) is a four decade old, Indian ..
|
Buy
|
4470
|
4900
|
9.62
|
|
|
30-Jul-22
|
KR Choksey
|
Dr. Reddy’s Laboratories reported adjusted Revenue growth at 1.2%..
|
Buy
|
4090
|
4869
|
19.05
|
|
|
24-May-22
|
KR Choksey
|
Dr. Reddy’s laboratories reported adj. revenue growth at 10.3% Yo..
|
Buy
|
4275
|
5261
|
23.1
|
|
|
2-Feb-22
|
KR Choksey
|
Dr. Reddy’s laboratories reported revenue growth at 8.0% YoY (-7...
|
Buy
|
4303
|
5261
|
22.3
|
|
|
3-Nov-21
|
KR Choksey
|
Dr. Reddy’s laboratories reported Revenue growth of 17.8% YoY (+1..
|
ACCUMULATE
|
4746
|
5261
|
10.85
|
|
asdsa
Upcoming Events and Recent Updates
|
|
24-Oct-25
|
Conference Transcript (Voice)
( updated on
Nov 03 2025)
|
|
30-Oct-25
|
Post ITs (Interesting Article)
-
Dr Reddy's plunges 6%, hits 5-month low; why pharma stock under pressure?
( updated on
Oct 30 2025)
|
|
27-Oct-25
|
Management Interview
-
Erez Israeli,CEO - Dr. Reddy’s Weak Earnings: Margins Slip to 23.3%, U.S. Pain Deepens | Share Market
( updated on
Oct 27 2025) 
|
|
|
27-Oct-25
|
Post ITs (Interesting Article)
-
Brokerages see near-term upside in Dr Reddy's on Semaglutide, ex-US growth
( updated on
Oct 27 2025)
|